Efficacy and Safety Evaluation in Recurrent Wheezing Attacks

Clinical trial NCT01734811 · COMPLETED

Trial details

NCT number: NCT01734811
Sponsor: Inmunotek S.L.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bronchospasm; Bronchiolitis Bronchospasm; Bronchitis

Start date: 2012-10-01
Primary completion: 2016-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.